Signal active
Contact Information
Social
Primary Organization
2018
11-50
Biotechnology, Health Care, Pharmaceutical, Biopharma
Bio
Sharon Tetlow has over a dozen years of experience as chief financial officer in life sciences, and a strong track record of strategic execution and raising capital. She was most recently senior vice president and CFO of Cell Genesys, a publicly traded biotechnology company in which she was instrumental in selling to BioSante (BPAX). She served as a venture partner at Apax Partners, a private equity and venture firm, and previously served as senior vice president and chief financial officer of diaDexus, where she raised private capital to fund the development and successful launch of the company’s first product. She also served as CFO of Reprogen and Terrapin, both private biotechnology companies. Prior to Terrapin, Ms. Tetlow worked in finance at Synergen, Genentech and Eli Lilly. Ms Tetlow began her career in Washington D.C. where she worked in consulting at Lewin and Associates and then at the Brookings Institution. She holds a BA from the University of Delaware and an MBA from Stanford University.
Location
San Francisco, California, United States, North America
Jobs history
2
Structure Therapeutics
Board Member
2022 - Current
Day One Biopharmaceuticals
Consulting Chief Financial Officer
Invalid date - Current
Educations
1
Stanford University
unknown
Profile Resume
Sharon Tetlow is the Consulting Chief Financial Officer at Day One Biopharmaceuticals, based in United States, North America. With a background in Biotechnology, Sharon Tetlow has a rich history of leadership and innovation.Sharon Tetlow studied MBA unknown at Stanford University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity
There is no recent news or activity for this profile.